Private equity firm Bain Capital has closed its first life sciences investment fund, named Bain Capital Life Sciences, at $720 million. The fund aims to invest $30 million to $70 million in private and public companies in the areas of medical devices, biotech and specialty pharmaceuticals and will take part in leveraged buyouts in collaboration with Bain Capital's private equity funds.
Bain Capital's life sciences fund gets $720M boost
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.